Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa).
Tiede A, Friedrich U, Stenmo C, Allen G, Giangrande P, Goudemand J, Hay C, Holmström M, Klamroth R, Lethagen S, McKenzie S, Miesbach W, Negrier C, Yuste VJ, Berntorp E.
Tiede A, et al. Among authors: klamroth r.
J Thromb Haemost. 2011 Jun;9(6):1191-9. doi: 10.1111/j.1538-7836.2011.04293.x.
J Thromb Haemost. 2011.
PMID: 21489128
Free article.
Clinical Trial.